AMA resolution backs classifying myopia as a disease, aiming to expand insurance coverage for pediatric myopia control treatments.

SightGlass Vision reports the milestone just 1 year after reaching 1 million users.

The findings extend prior Asian efficacy data to a diverse North American cohort for Stellest lenses.

Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management.

Monica Jong, OD, PhD, FAAO, FBCLA, discussed how recent developments in the field of myopia will transform eye care providers' approach to management.

The meeting will include an Open Public Hearing.

Monica Jong, BOptom, PhD, FAAO, FBCLA, discussed the latest findings on Stellest lenses' effectiveness in myopia progression control and her advice for optometrists integrating the lenses into practice.

Roman-Lantzy, PhD, gives an urgent plea to eye care providers, whom she calls "the gatekeepers of the entire story" for pediatric patients with CVI.